The Roles of Insulin-Like Growth Factors in Mesenchymal Stem Cell Niche

Overview

Journal Stem Cells Int

Publisher Wiley

Specialty Cell Biology

Date 2017 Mar 17

PMID 28298931

Citations 58

Authors

Amer Youssef

Doaa Aboalola

Victor K M Han

Affiliations

Soon will be listed here.

Abstract

Many tissues contain adult mesenchymal stem cells (MSCs), which may be used in tissue regeneration therapies. However, the MSC availability in most tissues is limited which demands expansion in vitro following isolation. Like many developing cells, the state of MSCs is affected by the surrounding microenvironment, and mimicking this natural microenvironment that supports multipotent or differentiated state in vivo is essential to understand for the successful use of MSC in regenerative therapies. Many researchers are, therefore, optimizing cell culture conditions in vitro by altering growth factors, extracellular matrices, chemicals, oxygen tension, and surrounding pH to enhance stem cells self-renewal or differentiation. Insulin-like growth factors (IGFs) system has been demonstrated to play an important role in stem cell biology to either promote proliferation and self-renewal or enhance differentiation onset and outcome, depending on the cell culture conditions. In this review, we will describe the importance of IGFs, IGF-1 and IGF-2, in development and in the MSC niche and how they affect the pluripotency or differentiation towards multiple lineages of the three germ layers.

Citing Articles

Calcium Chloride vs. Mechanical Preparation of Fibrinogen-Depleted Human Platelet Lysate: Implications for Umbilical Cord Mesenchymal Stem Cell Culture.

Lim Y, Barathan M, Tan Y, Lee Y, Law J Life (Basel). 2025; 15(1).

PMID: 39859952 PMC: 11766796. DOI: 10.3390/life15010012.

Forty Years of the Use of Cells for Cartilage Regeneration: The Research Side.

Roseti L, Cavallo C, Desando G, DAlessandro M, Grigolo B Pharmaceutics. 2025; 16(12.

PMID: 39771600 PMC: 11677864. DOI: 10.3390/pharmaceutics16121622.

The Well-Forgotten Old: Platelet-Rich Plasma in Modern Anti-Aging Therapy.

Gorodilova A, Kharisova C, Osinnikova M, Kitaeva K, Filin I, Mayasin Y Cells. 2024; 13(21.

PMID: 39513862 PMC: 11545519. DOI: 10.3390/cells13211755.

Decoding the Role of Insulin-like Growth Factor 1 and Its Isoforms in Breast Cancer.

Kotsifaki A, Maroulaki S, Karalexis E, Stathaki M, Armakolas A Int J Mol Sci. 2024; 25(17).

PMID: 39273251 PMC: 11394947. DOI: 10.3390/ijms25179302.

Comparing the Soluble Form of Recombinant Human Insulin-like Growth Factor-1 (rhIGF-1) in Using Thioredoxin as Fused and Co-expressed Protein.

Hemmati S, Maghami P, Ranjbari J, Tabarzad M Protein Pept Lett. 2024; 31(6):469-478.

PMID: 38963110 DOI: 10.2174/0109298665314267240624091046.

References

Esposito D, Li Y, Cama A, Quon M . Tyr(612) and Tyr(632) in human insulin receptor substrate-1 are important for full activation of insulin-stimulated phosphatidylinositol 3-kinase activity and translocation of GLUT4 in adipose cells. Endocrinology. 2001; 142(7):2833-40. DOI: 10.1210/endo.142.7.8283. View

Chaker Z, Aid S, Berry H, Holzenberger M . Suppression of IGF-I signals in neural stem cells enhances neurogenesis and olfactory function during aging. Aging Cell. 2015; 14(5):847-56. PMC: 4568972. DOI: 10.1111/acel.12365. View

De Magalhaes Filho C, Kappeler L, Dupont J, Solinc J, Villapol S, Denis C . Deleting IGF-1 receptor from forebrain neurons confers neuroprotection during stroke and upregulates endocrine somatotropin. J Cereb Blood Flow Metab. 2016; 37(2):396-412. PMC: 5381438. DOI: 10.1177/0271678X15626718. View

Bach L, Hsieh S, Sakano K, Fujiwara H, Perdue J, Rechler M . Binding of mutants of human insulin-like growth factor II to insulin-like growth factor binding proteins 1-6. J Biol Chem. 1993; 268(13):9246-54. View

Myers Jr M, Grammer T, Wang L, Sun X, PIERCE J, Blenis J . Insulin receptor substrate-1 mediates phosphatidylinositol 3'-kinase and p70S6k signaling during insulin, insulin-like growth factor-1, and interleukin-4 stimulation. J Biol Chem. 1994; 269(46):28783-9. View

Zvaifler N, Marinova-Mutafchieva L, Adams G, Edwards C, Moss J, Burger J . Mesenchymal precursor cells in the blood of normal individuals. Arthritis Res. 2000; 2(6):477-88. PMC: 17820. DOI: 10.1186/ar130. View

Chen L, Jiang W, Huang J, He B, Zuo G, Zhang W . Insulin-like growth factor 2 (IGF-2) potentiates BMP-9-induced osteogenic differentiation and bone formation. J Bone Miner Res. 2010; 25(11):2447-59. PMC: 3179288. DOI: 10.1002/jbmr.133. View

Edmondson S, Thumiger S, Werther G, Wraight C . Epidermal homeostasis: the role of the growth hormone and insulin-like growth factor systems. Endocr Rev. 2003; 24(6):737-64. DOI: 10.1210/er.2002-0021. View

Pumberger M, Qazi T, Ehrentraut M, Textor M, Kueper J, Stoltenburg-Didinger G . Synthetic niche to modulate regenerative potential of MSCs and enhance skeletal muscle regeneration. Biomaterials. 2016; 99:95-108. DOI: 10.1016/j.biomaterials.2016.05.009. View

10.

Sanchez-Ramos J, Song S, Cardozo-Pelaez F, HAZZI C, Stedeford T, Willing A . Adult bone marrow stromal cells differentiate into neural cells in vitro. Exp Neurol. 2000; 164(2):247-56. DOI: 10.1006/exnr.2000.7389. View

11.

Kearns-Jonker M, Dai W, Gunthart M, Fuentes T, Yeh H, Gerczuk P . Genetically Engineered Mesenchymal Stem Cells Influence Gene Expression in Donor Cardiomyocytes and the Recipient Heart. J Stem Cell Res Ther. 2012; S1. PMC: 3487477. DOI: 10.4172/2157-7633.s1-005. View

12.

Ayatollahi M, Soleimani M, Geramizadeh B, Imanieh M . Insulin-like growth factor 1 (IGF-I) improves hepatic differentiation of human bone marrow-derived mesenchymal stem cells. Cell Biol Int. 2011; 35(11):1169-76. DOI: 10.1042/CBI20110016. View

13.

van der Geer P, Wiley S, Gish G, Lai V, Stephens R, White M . Identification of residues that control specific binding of the Shc phosphotyrosine-binding domain to phosphotyrosine sites. Proc Natl Acad Sci U S A. 1996; 93(3):963-8. PMC: 40012. DOI: 10.1073/pnas.93.3.963. View

14.

Hsieh A, Ellsworth R, Hsieh D . Hedgehog/GLI1 regulates IGF dependent malignant behaviors in glioma stem cells. J Cell Physiol. 2010; 226(4):1118-27. DOI: 10.1002/jcp.22433. View

15.

Ye P, Hu Q, Liu H, Yan Y, DErcole A . beta-catenin mediates insulin-like growth factor-I actions to promote cyclin D1 mRNA expression, cell proliferation and survival in oligodendroglial cultures. Glia. 2010; 58(9):1031-41. PMC: 2917840. DOI: 10.1002/glia.20984. View

16.

Frasca F, Pandini G, Scalia P, Sciacca L, MINEO R, Costantino A . Insulin receptor isoform A, a newly recognized, high-affinity insulin-like growth factor II receptor in fetal and cancer cells. Mol Cell Biol. 1999; 19(5):3278-88. PMC: 84122. DOI: 10.1128/MCB.19.5.3278. View

17.

Wang J, Zhou J, Bondy C . Igf1 promotes longitudinal bone growth by insulin-like actions augmenting chondrocyte hypertrophy. FASEB J. 1999; 13(14):1985-90. DOI: 10.1096/fasebj.13.14.1985. View

18.

Roberts C, Owens J, Carter A, Harding J, Austgulen R, Wlodek M . Insulin-like growth factors and foetal programming--a workshop report. Placenta. 2003; 24 Suppl A:S72-5. DOI: 10.1053/plac.2002.0935. View

19.

Zhang G, Gu T, Guan X, Sun X, Qi X, Li X . HGF and IGF-1 promote protective effects of allogeneic BMSC transplantation in rabbit model of acute myocardial infarction. Cell Prolif. 2015; 48(6):661-70. PMC: 6496765. DOI: 10.1111/cpr.12219. View

20.

Reyon D, Tsai S, Khayter C, Foden J, Sander J, Joung J . FLASH assembly of TALENs for high-throughput genome editing. Nat Biotechnol. 2012; 30(5):460-5. PMC: 3558947. DOI: 10.1038/nbt.2170. View